Androscoggin Cardiology Associates

Auburn, Maine 04210

0 studies enrolling now · 11 studies all time

What they study most

Atrial Fibrillation, Atrial Flutter, Cardiomyopathy, Cardiovascular Disease, Combined Hyperlipidemia, Congestive Heart Failure, Coronary Arteriosclerosis, Coronary Artery Disease, Diabetes Mellitus, Non-Insulin-Dependent, Heart Disease, Hypertension, Intermittent Claudication

Studies at this site

• A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia — Completed
• DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant Hypertension — Stopped early
• The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN? — Completed
• EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan — Completed
• Both Exercise and Adenosine Stress Testing — Stopped early
• Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation — Status unconfirmed
• Obese Patients With Type 2 Diabetes — Completed
• PROVIDENCE-1: Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients — Status unconfirmed
• Trial of VLTS-589 in Subjects With Intermittent Claudication — Completed
• Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients — Completed
• Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients — Completed